These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. Association between MRI parameters and the MS severity scale: a 12 year follow-up study. Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751 [TBL] [Abstract][Full Text] [Related]
72. Differentiating multiple sclerosis from other causes of demyelination using diffusion weighted imaging of the corpus callosum. Straus Farber R; Devilliers L; Miller A; Lublin F; Law M; Fatterpekar G; Delman B; Naidich T J Magn Reson Imaging; 2009 Oct; 30(4):732-6. PubMed ID: 19787715 [TBL] [Abstract][Full Text] [Related]
73. Neurogenic pulmonary edema. Locke CF; Sing RF; Sing RF J Am Osteopath Assoc; 1993 Mar; 93(3):382-4. PubMed ID: 8514537 [TBL] [Abstract][Full Text] [Related]
74. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020 [TBL] [Abstract][Full Text] [Related]
75. Selective vulnerability of inhibitory networks in multiple sclerosis. Zoupi L; Booker SA; Eigel D; Werner C; Kind PC; Spires-Jones TL; Newland B; Williams AC Acta Neuropathol; 2021 Mar; 141(3):415-429. PubMed ID: 33449171 [TBL] [Abstract][Full Text] [Related]
76. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis. Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860 [TBL] [Abstract][Full Text] [Related]
77. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Sormani MP; Rovaris M; Comi G; Filippi M Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123 [TBL] [Abstract][Full Text] [Related]
78. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153 [TBL] [Abstract][Full Text] [Related]
79. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142 [TBL] [Abstract][Full Text] [Related]